HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Laparoscopic occlusion compared with embolization of uterine vessels: a randomized controlled trial.

AbstractOBJECTIVE:
To compare clinical outcome 6 months after treatment with bilateral laparoscopic occlusion of the uterine artery versus uterine leiomyoma embolization.
METHODS:
Sixty-six premenopausal women with symptomatic uterine leiomyomata were randomized to treatment with either laparoscopic occlusion of uterine arteries or uterine leiomyoma embolization. The primary outcome was reduction of blood loss from pretreatment to 6 months postoperatively, measured by a Pictorial Bleeding Assessment Chart. Secondary outcomes included patients' own assessment of symptom reduction, postoperative pain assessed using visual analog scales, ketobemidone used postoperatively, complications, secondary interventions, and failures.
RESULTS:
Fifty-eight women were included; 6-month follow-up data were available for 28 participants in each group. The percentage reduction in Pictorial Bleeding Assessment Chart scores did not differ between the treatment groups (52% after uterine leiomyoma embolization and 53% after laparoscopy, P=.96). The study had 52% power to detect a 20% difference on the Pictorial Bleeding Assessment Chart. Fewer participants in the group treated with uterine leiomyoma embolization complained of heavy bleeding after 6 months (4% compared with 21%, P=.044). The postoperative use of ketobemidone was higher after uterine leiomyoma embolization (46 mg compared with 12 mg, P<.001).
CONCLUSION:
Both laparoscopic occlusion of uterine vessels and embolizaton of uterine leiomyoma improved clinical symptoms in the majority of patients. Participants with the laparoscopic procedure had less postoperative pain but heavier menstrual bleeding 6 months after treatment. A larger study and longer follow-up is necessary before a definite conclusion can be made regarding the most effective treatment.
CLINICAL TRIAL REGISTRATION:
(www.ClinicalTrials.gov), NCT00277680
LEVEL OF EVIDENCE:
I.
AuthorsKirsten Hald, Nils-Einar Kløw, Erik Qvigstad, Olav Istre
JournalObstetrics and gynecology (Obstet Gynecol) Vol. 109 Issue 1 Pg. 20-7 (Jan 2007) ISSN: 0029-7844 [Print] United States
PMID17197583 (Publication Type: Comparative Study, Journal Article, Randomized Controlled Trial)
Chemical References
  • Analgesics, Opioid
  • Meperidine
  • ketobemidone
Topics
  • Adult
  • Analgesics, Opioid (administration & dosage)
  • Embolization, Therapeutic (adverse effects)
  • Female
  • Humans
  • Laparoscopy (adverse effects)
  • Leiomyoma (therapy)
  • Menorrhagia (therapy)
  • Meperidine (administration & dosage, analogs & derivatives)
  • Middle Aged
  • Nausea (etiology)
  • Pain, Postoperative (drug therapy)
  • Pressure
  • Recovery of Function
  • Treatment Outcome
  • Uterine Neoplasms (therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: